Silence Therapeutics PLC
NASDAQ:SLN
Income Statement
Earnings Waterfall
Silence Therapeutics PLC
Revenue
|
1.4m
GBP
|
Operating Expenses
|
-28.6m
GBP
|
Operating Income
|
-27.2m
GBP
|
Other Expenses
|
4.8m
GBP
|
Net Income
|
-22.4m
GBP
|
Income Statement
Silence Therapeutics PLC
Dec-2019 | Jun-2020 | ||
---|---|---|---|
Revenue | |||
Revenue |
0
N/A
|
1
+470%
|
|
Operating Income | |||
Operating Expenses |
(23)
|
(29)
|
|
Selling, General & Administrative |
(10)
|
(10)
|
|
Research & Development |
(13)
|
(18)
|
|
Operating Income |
(23)
N/A
|
(27)
-20%
|
|
Pre-Tax Income | |||
Interest Income Expense |
(0)
|
1
|
|
Pre-Tax Income |
(23)
N/A
|
(27)
-16%
|
|
Net Income | |||
Tax Provision |
3
|
4
|
|
Income from Continuing Operations |
(20)
|
(22)
|
|
Net Income (Common) |
(20)
N/A
|
(22)
-14%
|
|
EPS (Diluted) |
-0.25
N/A
|
-0.28
-12%
|